Nephros (NEPH) EBITDA Margin Growth (3y) (2013 - 2026)
Nephros (NEPH) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 722.00 |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 205.00 |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -2,360.00 |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 612.00 |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -368.00 |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -1,189.00 |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -1,384.00 |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 799.00 |
| 10 | Nephros | 48.26 Mn | 43.56 Mn | 4.03 Mn | 3,243.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,243.00 |
| Mar 31, 2026 | 1,014.00 |
| Dec 31, 2025 | 2,747.00 |
| Sep 30, 2025 | 5,977.00 |
| Jun 30, 2025 | 3,417.00 |
| Mar 31, 2025 | 8,326.00 |
| Dec 31, 2024 | 3,477.00 |
| Sep 30, 2024 | 3,696.00 |
| Jun 30, 2024 | 3,955.00 |
| Mar 31, 2024 | 3,153.00 |
| Dec 31, 2023 | 1,086.00 |
| Sep 30, 2023 | 3,852.00 |
| Jun 30, 2023 | 8,906.00 |
| Mar 31, 2023 | 3,229.00 |
| Dec 31, 2022 | -1,789.00 |
| Sep 30, 2022 | -3,072.00 |
| Jun 30, 2022 | 903.00 |
| Mar 31, 2022 | 189.00 |
| Dec 31, 2021 | 1,865.00 |
| Sep 30, 2021 | -147.00 |